InvestorsHub Logo
Followers 1524
Posts 89537
Boards Moderated 7
Alias Born 05/09/2004

Re: konshe post# 30600

Tuesday, 04/05/2022 11:34:23 PM

Tuesday, April 05, 2022 11:34:23 PM

Post# of 31828
"The Company remains optimistic that full List-N approval from the Environmental Protection Agency (EPA) is drawing near, but does not need the broader approval to begin its sales initiative to obvious market opportunities or to fulfill a substantial bounty of current purchase orders. The Company is currently fulfilling Purchase Orders and all of this has been done without any formal marketing and mostly local word-of-mouth.

Starting in March 2022 the Company will for the first time launch a full marketing campaign which will be officiated by renowned marketing firm, Wallrich Creative Communications.

Using the greatly expanded manufacturing capacity of its new Grass Valley facility which the Company believes, when fully utilized, has the ability to produce twenty-five thousand cases per year with a potential estimated wholesale value of over ten million dollars.

The Company believes that its BioDox pathogen prevention product is ideal for the vast Agricultural industry where the prevention of crop loss to pathogens can greatly increase profits vis-à-vis larger harvests and for what is a relatively small expense.

“In 2021, we were able to test market our BioDox formula in various agricultural sectors where it was used to prevent pathogens from destroying entire crops,” stated Justin Gonzalez, Chairman & CEO, Boon Industries,.

“Our active customers immediately realized more value in preventative treatment rather than treating the after-effects of the damage caused by pathogens in agricultural crops.”


The Company has already identified over 18,000 cultivators, specifically, those farmers who continue to experience dwindling profit margins from crop loss, as they focus on cost/risk management to grow healthy crops. This small agricultural sector alone represents a $180 million market opportunity for the Boon sales team to pursue.

“Our full-force sales of BioDox begin this quarter with an anticipated first professional marketing campaign,” added Gonzalez. “We are highly optimistic in the results for that campaign based on prior test marketing and response. We believe that BioDox can become an industry leader in pathogen infestation treatments in specialized agriculture as farmers turn their focus from the high-risk plan of treatment to prevention. This creates a significant opportunity for Boon Industries to carve out market share in the overall $10 trillion Agricultural market.”


https://finance.yahoo.com/news/boon-industries-begin-sales-initiative-130000227.html